Ionis Pharmaceuticals Inc (IONS) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 
Ionis Pharmaceuticals Inc   (NASDAQ: IONS)
 

Ionis Pharmaceuticals Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the second quarter 2026, Ionis Pharmaceuticals Inc 's inventory turnover ratio sequentially decreased to 0.42 in the second quarter 2026, unsurprisingly, as the Ionis Pharmaceuticals Inc markets continue to deteriorate, and IONS's faces growing challenges to bring down its inventories. Ionis Pharmaceuticals Inc 's average inventory processing period in the Jun 30 2026 quarter, has increased to 869 days, from 332 days, in the Mar 31 2026 quarter.

Within Healthcare sector 352 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1556 in the first quarter 2026, to 1817.

IONS Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Ionis Pharmaceuticals Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

IONS Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
2025		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth 499.38 % -51.69 % -19.69 % -63.2 % -70.47 %
Y / Y Cost of Sales Growth -34.02 % 103.9 % - 118.3 % -0.31 %
Inventory Turnover Ratio (TTM) 0.42 1.1 - 1.1 0.69
IONS's Total Ranking # 1817 # 1556 # 358 # 360 #
Average inventory processing period 871 333 - 333 529
Seq. Inventory Growth 814.76 % -44.7 % -4.03 % 23.45 % -26.26 %
Seq. Cost of Sales Growth -8.18 % - - -43.68 % 183.73 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 111
Healthcare Sector # 353
Overall Market # 1817

Inventory Turnover Ratio Statistics
High Average Low
12.86 0.95 0.26
(Jun 30 2019)   (Dec 31 2019)



IONS Company Profile >> Back to IONS Efficiency Comparisons >> Compare IONS Inventory Turnover Ratio to its Competitors

Financial Statements
Ionis Pharmaceuticals Inc 's Inventories $ 51 Millions Visit IONS's Balance sheet
Ionis Pharmaceuticals Inc 's Cost of Revenues TTM $ 8 Millions Visit IONS's Income Statement
What are IONS's Sales? Visit IONS's Sales by Segment

Other Inventory Turnover Ratios
Ionis Pharmaceuticals Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
IONS's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for IONS's Competitors
Inventory Turnover Ratio for IONS's Suppliers
Inventory Turnover Ratio for IONS's Customers

You may also want to know
IONS's Sales Growth Rates IONS's Pe Price to earnings ratio IONS's Receivables Turnover Ratio IONS's Stock Quote
IONS's Net Income Growth Rates IONS's Ps Price to Sales ratio IONS's Sales per Employee IONS's Asset Turnover Ratio
IONS's Net Margin IONS's Pb Price to Book ratio IONS's Financial Strength Ratios IONS's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Immunitybio inc   0.43 $ 1.095  Millions$ 3  Millions
Pelthos Therapeutics Inc   0.40 $ 9.271  Millions$ 23  Millions
EBR Systems, Inc.  0.39 $ 5.514  Millions$ 14  Millions
Aspire Biopharma Holdings Inc   0.34 $ 0.080  Millions$ 0  Millions
Guided Therapeutics Inc   0.32 $ 0.158  Millions$ 1  Millions
Invo Fertility Inc   0.29 $ 0.065  Millions$ 0  Millions
Outlook Therapeutics Inc   0.26 $ 0.985  Millions$ 4  Millions
Agios Pharmaceuticals Inc   0.23 $ 7.873  Millions$ 34  Millions
Alpha Cognition Inc.  0.23 $ 1.250  Millions$ 6  Millions
Verrica Pharmaceuticals Inc   0.17 $ 0.400  Millions$ 2  Millions
Nexalin Technology Inc   0.17 $ 0.030  Millions$ 0  Millions
Femasys Inc   0.15 $ 0.898  Millions$ 6  Millions
Yubo International Biotech Limited  0.15 $ 0.004  Millions$ 0  Millions
Bioadaptives Inc   0.14 $ 0.006  Millions$ 0  Millions
Madrigal Pharmaceuticals Inc   0.12 $ 10.400  Millions$ 89  Millions
Citius Pharmaceuticals Inc   0.07 $ 1.610  Millions$ 22  Millions
Ptc Therapeutics inc   0.05 $ 3.600  Millions$ 75  Millions
Adagio Medical Holdings inc   0.05 $ 0.089  Millions$ 2  Millions
Citius Oncology Inc  0.04 $ 0.821  Millions$ 21  Millions

Date modified: 2026-10-05T11:03:41+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.